Skip to main content
Erschienen in: Virchows Archiv 3/2014

01.09.2014 | Original Article

Thymoma with loss of keratin expression (and giant cells): a potential diagnostic pitfall

verfasst von: Patrick Adam, Samy Hakroush, Ilse Hofmann, Sonja Reidenbach, Alexander Marx, Philipp Ströbel

Erschienen in: Virchows Archiv | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Due to its profound therapeutic consequences, the distinction between thymoma and T-lymphoblastic lymphoma in needle biopsies is one of the most challenging in mediastinal pathology. One essential diagnostic criterion favouring thymoma is the demonstration of increased numbers of keratin-positive epithelial cells by immunohistochemistry. Loss of keratin expression in neoplastic epithelial cells could lead to detrimental misdiagnoses. We here describe a series of 14 thymic epithelial tumours (11 type B2 and B3 thymomas, 3 thymic carcinomas) with loss of expression of one or more keratins. Cases were analysed for expression of various keratins and desmosomal proteins by immunohistochemistry and immunofluorescence and compared with 45 unselected type B thymomas and 24 thymic carcinomas arranged in a multitissue histological array. All 14 cases showed highly reduced expression of at least one keratin, three cases were completely negative for all keratins studied. Of the 14 cases, 13 showed strong nuclear expression of p63. Expression of desmosomal proteins was preserved, suggesting intact cell contact structures. Loss of expression of broad-spectrum-keratins and K19 was observed in 3 and 5 % of unselected thymomas and in 30 and 60 % of thymic carcinomas. A proportion of keratin-depleted thymomas contained giant cells, reminiscent of thymic nurse cells. Loss of keratin expression in type B2 and B3 thymomas is an important diagnostic pitfall in the differential diagnosis with T-lymphoblastic lymphoma and can be expected in 5 % of cases. A panel of epithelial markers including p63 is warranted to ensure correct diagnosis of keratin-negative mediastinal tumours.
Literatur
1.
Zurück zum Zitat Bersvendsen H, Kolstad A, Blystad AK, Aurlien E, Fossa A, Kvaloy SO, Holte H, Lauritzsen GF (2013) Multimodal treatment with ALL-like chemotherapy, Auto-SCT and radiotherapy for lymphoblastic lymphoma Acta Oncol Bersvendsen H, Kolstad A, Blystad AK, Aurlien E, Fossa A, Kvaloy SO, Holte H, Lauritzsen GF (2013) Multimodal treatment with ALL-like chemotherapy, Auto-SCT and radiotherapy for lymphoblastic lymphoma Acta Oncol
2.
Zurück zum Zitat Borowitz MJ, Chan JKC (2008) T lymphoblastic leukaemia/lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO Classification of Tumours of haematopoietic and lymphoid tissues. IARC, Lyon, pp 176–179 Borowitz MJ, Chan JKC (2008) T lymphoblastic leukaemia/lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO Classification of Tumours of haematopoietic and lymphoid tissues. IARC, Lyon, pp 176–179
3.
Zurück zum Zitat Friedman HD, Hutchison RE, Kohman LJ, Powers CN (1996) Thymoma mimicking lymphoblastic lymphoma: a pitfall in fine-needle aspiration biopsy interpretation. Diagn Cytopathol 14:165–169, discussion 169–171PubMedCrossRef Friedman HD, Hutchison RE, Kohman LJ, Powers CN (1996) Thymoma mimicking lymphoblastic lymphoma: a pitfall in fine-needle aspiration biopsy interpretation. Diagn Cytopathol 14:165–169, discussion 169–171PubMedCrossRef
4.
Zurück zum Zitat Hendrix TM, Chilukuri RV, Martinez M, Olushoga Z, Blake A, Brohi M, Walker C, Samms M, Guyden JC (2010) Thymic nurse cells exhibit epithelial progenitor phenotype and create unique extra-cytoplasmic membrane space for thymocyte selection. Cell Immunol 261:81–92PubMedCentralPubMedCrossRef Hendrix TM, Chilukuri RV, Martinez M, Olushoga Z, Blake A, Brohi M, Walker C, Samms M, Guyden JC (2010) Thymic nurse cells exhibit epithelial progenitor phenotype and create unique extra-cytoplasmic membrane space for thymocyte selection. Cell Immunol 261:81–92PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Kuo T (2000) Cytokeratin profiles of the thymus and thymomas: histogenetic correlations and proposal for a histological classification of thymomas. Histopathology 36:403–414PubMedCrossRef Kuo T (2000) Cytokeratin profiles of the thymus and thymomas: histogenetic correlations and proposal for a histological classification of thymomas. Histopathology 36:403–414PubMedCrossRef
6.
Zurück zum Zitat Li S, Juco J, Mann KP, Holden JT (2004) Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma. Am J Clin Pathol 121:268–274PubMedCrossRef Li S, Juco J, Mann KP, Holden JT (2004) Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma. Am J Clin Pathol 121:268–274PubMedCrossRef
7.
Zurück zum Zitat Müller-Hermelink HK, Engel P, Kuo TT, Strobel P, Marx A, Harris NL, Möller P, Menestrina F, Shimosato Y, Asamura H, Masaoka A, Sobin LH (2004) Tumours of the thymus: introduction. In: Travis MD, Brambilla E, Müller-Hermelink HK, Harris CC (eds) World Health Organization Classification of tumours. pathology and genetics of tumours of the lung, thymus and heart. IARC Press, Lyon, pp 145–151 Müller-Hermelink HK, Engel P, Kuo TT, Strobel P, Marx A, Harris NL, Möller P, Menestrina F, Shimosato Y, Asamura H, Masaoka A, Sobin LH (2004) Tumours of the thymus: introduction. In: Travis MD, Brambilla E, Müller-Hermelink HK, Harris CC (eds) World Health Organization Classification of tumours. pathology and genetics of tumours of the lung, thymus and heart. IARC Press, Lyon, pp 145–151
8.
Zurück zum Zitat Muller-Hermelink HK, Marx A (2000) Thymoma Curr Opin Oncol 12:426–433CrossRef Muller-Hermelink HK, Marx A (2000) Thymoma Curr Opin Oncol 12:426–433CrossRef
9.
Zurück zum Zitat Müller-Hermelink HK, Sng I, Palestro G, Molina TJ, Laeng RH, Harris NL, Zhang PJ, Marx A (2004) Type B2 thymoma. In: Travis MD, Brambilla E, Müller-Hermelink HK, Harris CC (eds) Pathology and Genetics of Tumours of the Lung, Pleura. Thymus and Heart. IARC Press, Lyon, pp 161–163 Müller-Hermelink HK, Sng I, Palestro G, Molina TJ, Laeng RH, Harris NL, Zhang PJ, Marx A (2004) Type B2 thymoma. In: Travis MD, Brambilla E, Müller-Hermelink HK, Harris CC (eds) Pathology and Genetics of Tumours of the Lung, Pleura. Thymus and Heart. IARC Press, Lyon, pp 161–163
10.
Zurück zum Zitat Palestro G, Chiarle R, Marx A, Müller-Hermelink HK, Sng I (2004) Type B1 thymoma. In: Travis MD, Brambilla E, Müller-Hermelink HK, Harris CC (eds) Pathology and Genetics of Tumours of the Lung, Pleura. Thymus and Heart. IARC Press, Lyon, pp 159–160 Palestro G, Chiarle R, Marx A, Müller-Hermelink HK, Sng I (2004) Type B1 thymoma. In: Travis MD, Brambilla E, Müller-Hermelink HK, Harris CC (eds) Pathology and Genetics of Tumours of the Lung, Pleura. Thymus and Heart. IARC Press, Lyon, pp 159–160
11.
Zurück zum Zitat Patel DD, Whichard LP, Radcliff G, Denning SM, Haynes BF (1995) Characterization of human thymic epithelial cell surface antigens: phenotypic similarity of thymic epithelial cells to epidermal keratinocytes. J Clin Immunol 15:80–92PubMedCrossRef Patel DD, Whichard LP, Radcliff G, Denning SM, Haynes BF (1995) Characterization of human thymic epithelial cell surface antigens: phenotypic similarity of thymic epithelial cells to epidermal keratinocytes. J Clin Immunol 15:80–92PubMedCrossRef
12.
Zurück zum Zitat Schweizer J, Bowden PE, Coulombe PA, Langbein L, Lane EB, Magin TM, Maltais L, Omary MB, Parry DA, Rogers MA, Wright MW (2006) New consensus nomenclature for mammalian keratins. J Cell Biol 174:169–174PubMedCentralPubMedCrossRef Schweizer J, Bowden PE, Coulombe PA, Langbein L, Lane EB, Magin TM, Maltais L, Omary MB, Parry DA, Rogers MA, Wright MW (2006) New consensus nomenclature for mammalian keratins. J Cell Biol 174:169–174PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Senoo M, Pinto F, Crum CP, McKeon F (2007) p63 Is essential for the proliferative potential of stem cells in stratified epithelia. Cell 129:523–536PubMedCrossRef Senoo M, Pinto F, Crum CP, McKeon F (2007) p63 Is essential for the proliferative potential of stem cells in stratified epithelia. Cell 129:523–536PubMedCrossRef
14.
Zurück zum Zitat Shezen E, Okon E, Ben-Hur H, Abramsky O (1995) Cytokeratin expression in human thymus: immunohistochemical mapping. Cell and Tissue Res 279:221–231CrossRef Shezen E, Okon E, Ben-Hur H, Abramsky O (1995) Cytokeratin expression in human thymus: immunohistochemical mapping. Cell and Tissue Res 279:221–231CrossRef
15.
Zurück zum Zitat Strobel P, Chuang WY, Chuvpilo S, Zettl A, Katzenberger T, Kalbacher H, Rieckmann P, Nix W, Schalke B, Gold R, Muller-Hermelink HK, Peterson P, Marx A (2008) Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms. Ann N Y Acad Sci 1132:143–156PubMedCrossRef Strobel P, Chuang WY, Chuvpilo S, Zettl A, Katzenberger T, Kalbacher H, Rieckmann P, Nix W, Schalke B, Gold R, Muller-Hermelink HK, Peterson P, Marx A (2008) Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms. Ann N Y Acad Sci 1132:143–156PubMedCrossRef
16.
Zurück zum Zitat Strobel P, Hohenberger P, Marx A (2010) Thymoma and thymic carcinoma: molecular pathology and targeted therapy. J Thorac Oncol 5:S286–S290PubMedCrossRef Strobel P, Hohenberger P, Marx A (2010) Thymoma and thymic carcinoma: molecular pathology and targeted therapy. J Thorac Oncol 5:S286–S290PubMedCrossRef
17.
Zurück zum Zitat Venuta F, Rendina EA, Anile M, de Giacomo T, Vitolo D, Coloni GF (2012) Thymoma and thymic carcinoma. Gen Thoracic and Cardiovasc Surg 60:1–12CrossRef Venuta F, Rendina EA, Anile M, de Giacomo T, Vitolo D, Coloni GF (2012) Thymoma and thymic carcinoma. Gen Thoracic and Cardiovasc Surg 60:1–12CrossRef
Metadaten
Titel
Thymoma with loss of keratin expression (and giant cells): a potential diagnostic pitfall
verfasst von
Patrick Adam
Samy Hakroush
Ilse Hofmann
Sonja Reidenbach
Alexander Marx
Philipp Ströbel
Publikationsdatum
01.09.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 3/2014
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-014-1606-6

Weitere Artikel der Ausgabe 3/2014

Virchows Archiv 3/2014 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …